Castration-resistant prostate cancer cells treated with metformin and simvastatin were shown to induce Ripk1- and Ripk3-dependent necrosis, suggesting that these necroptosis molecules may be important in the antitumor effects mediated by metformin [42]. The gene discussed is RIPK3; the disease is prostate cancer.